id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4203-0034,FDA,FDA-2019-N-4203,"Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Change of Name and Function; Technical Amendment",Rule,Final Rule,2022-03-23T04:00:00Z,2022,3,2022-03-23T04:00:00Z,,2022-03-23T13:16:06Z,2022-05965,0,0,0900006484fdacce